TY - JOUR
T1 - Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder
AU - Brownstein, Catherine A.
AU - Douard, Elise
AU - Mollon, Josephine
AU - Smith, Richard
AU - Hojlo, Margaret A.
AU - Das, Ananth
AU - Goldman, Maria
AU - Garvey, Emily
AU - Cabral, Kristin
AU - Li, Jianqiao
AU - Bowen, Joshua
AU - Rao, Abhijit S.
AU - Genetti, Casie
AU - Carroll, Devon
AU - Knowles, Emma E.M.
AU - Deaso, Emma
AU - Agrawal, Pankaj B.
AU - Beggs, Alan H.
AU - D'Angelo, Eugene
AU - Almasy, Laura
AU - Alexander-Bloch, Aaron
AU - Saci, Zohra
AU - Moreau, Clara A.
AU - Huguet, Guillaume
AU - Deo, Anthony J.
AU - Jacquemont, Sébastien
AU - Glahn, David C.
AU - Gonzalez-Heydrich, Joseph
N1 - Funding Information:
This work was funded by the Tommy Fuss Center for Neuropsychiatric Research, Boston Children’s Hospital Intellectual and Developmental Disabilities Research Center Molecular Genetics Core Facility supported by P50HD105351 from the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development, and by NIMH grant U01 MH119690, the Stanley Center of the Broad Institute of MIT and Harvard, and the Jonathan and Robin Klein and Anne and Paul Marcus families. The authors gratefully acknowledge the patients and families who participated in this study.
Publisher Copyright:
© 2022 American Psychiatric Association. All rights reserved.
PY - 2022/11
Y1 - 2022/11
N2 - Objective: Copy number variants (CNVs) are strongly associated with neurodevelopmental and psychotic disorders. Early-onset psychosis (EOP), where symptoms appear before 18 years of age, is thought to be more strongly influenced by genetic factors than adult-onset psychotic disorders. However, the prevalence and effect of CNVs in EOP is unclear. Methods: The authors documented the prevalence of recurrent CNVs and the functional impact of deletions and duplications genome-wide in 137 children and adolescents with EOP compared with 5,540 individuals with autism spectrum disorder (ASD) and 16,504 population control subjects. Specifically, the frequency of 47 recurrent CNVs previously associated with neurodevelopmental and neuropsychiatric illnesses in each cohort were compared. Next, CNV risk scores (CRSs), indices reflecting the dosage sensitivity for any gene across the genome that is encapsulated in a deletion or duplication separately, were compared between groups. Results: The prevalence of recurrent CNVs was significantly higher in the EOP group than in the ASD (odds ratio=2.30) and control (odds ratio=5.06) groups. However, the difference between the EOP and ASD groups was attenuated when EOP participants with co-occurring ASD were excluded. CRS was significantly higher in the EOP group compared with the control group for both deletions (odds ratio=1.30) and duplications (odds ratio=1.09). In contrast, the EOP and ASD groups did not differ significantly in terms of CRS. Conclusions: Given the high frequency of recurrent CNVs in the EOP group and comparable CRSs in the EOP and ASD groups, the findings suggest that all children and adolescents with a psychotic diagnosis should undergo genetic screening, as is recommended in ASD.
AB - Objective: Copy number variants (CNVs) are strongly associated with neurodevelopmental and psychotic disorders. Early-onset psychosis (EOP), where symptoms appear before 18 years of age, is thought to be more strongly influenced by genetic factors than adult-onset psychotic disorders. However, the prevalence and effect of CNVs in EOP is unclear. Methods: The authors documented the prevalence of recurrent CNVs and the functional impact of deletions and duplications genome-wide in 137 children and adolescents with EOP compared with 5,540 individuals with autism spectrum disorder (ASD) and 16,504 population control subjects. Specifically, the frequency of 47 recurrent CNVs previously associated with neurodevelopmental and neuropsychiatric illnesses in each cohort were compared. Next, CNV risk scores (CRSs), indices reflecting the dosage sensitivity for any gene across the genome that is encapsulated in a deletion or duplication separately, were compared between groups. Results: The prevalence of recurrent CNVs was significantly higher in the EOP group than in the ASD (odds ratio=2.30) and control (odds ratio=5.06) groups. However, the difference between the EOP and ASD groups was attenuated when EOP participants with co-occurring ASD were excluded. CRS was significantly higher in the EOP group compared with the control group for both deletions (odds ratio=1.30) and duplications (odds ratio=1.09). In contrast, the EOP and ASD groups did not differ significantly in terms of CRS. Conclusions: Given the high frequency of recurrent CNVs in the EOP group and comparable CRSs in the EOP and ASD groups, the findings suggest that all children and adolescents with a psychotic diagnosis should undergo genetic screening, as is recommended in ASD.
UR - http://www.scopus.com/inward/record.url?scp=85141004974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141004974&partnerID=8YFLogxK
U2 - 10.1176/appi.ajp.21111175
DO - 10.1176/appi.ajp.21111175
M3 - Article
C2 - 36000218
AN - SCOPUS:85141004974
SN - 0002-953X
VL - 179
SP - 853
EP - 861
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 11
ER -